Highlights from the IPSEN Satellite Symposium, 2014 BSRM Annual Scientific Meeting

Posted in Sponsored Feature on 22nd Jan 2015

Innovation in Rehabilitation Medicine

This was the focus of the first ever satellite symposium of the Annual Scientific Meeting of the British Society of Rehabilitation Medicine (BSRM) which explored “Recent advances in neurorehabilitation” and was sponsored by IPSEN. Leading three sessions was Dr Peter Aitken, Chair of the Faculty of Liaison Psychiatry, Royal College of Psychiatry. Dr Aitken began the symposium with a thought provoking talk on “Emerging techniques in patient motivation” looking specifically at motivation in rehabilitation.

ACNRJF15-25Motivation in Rehabilitation

There are many challenges throughout the rehabilitation journey, and for patients perhaps one of the biggest challenges is ensuring the rehabilitation process is sufficiently stimulating, helping them to maintain a positive outlook. One approach is to have ongoing support from the likes of a professional trainer, who can also act as a “buddy”, or as the renowned journalist, Andrew Marr once said, “a wise bully”, when referring to his professional trainer.

The introduction of electronic games as a rehabilitation aid is arguably one of the most significant advances in motivating the rehabilitation process. They have certainly helped to transform a process that has previously been regarded as dull and boring into an activity that people happily adhere to, both in the hospital and at home. What’s more, the use of computer games supports another established motivational technique of ‘practice and reward’ and encourages goal setting.

Dr Aitken went on to talk about the importance of setting ‘Smart’ Goals i.e. goals that are specific, measurable, achievable, realistic, and time-framed, as such goals are often used to aid the coordination between a multidisciplinary rehabilitation team when developing a rehabilitation plan for the individual needs of patients. Those goals then become an essential part of the rehabilitation feedback loop which includes monitoring progress against; the goals, other patients, and the literature. Then, we need to look at and measure the outcome of the rehabilitation process which includes:

•      Patient reported outcomes

•      Clinical reported outcomes

•      Patient experience

Real World Data – Supporting Rehabilitation Services

Capturing and recording outcome data to support rehabilitation services was the focus of the second presentation by Ravi Patel, from Document Capture Company (DCC). Ravi highlighted how measuring outcomes has greatly informed the commissioning of services and has encourage services to highlight their achievements. He also explained how, by automating collection of outcome data, using the likes of the Goal Attainment Scale (GAS) and the Therapy Outcome Measure (TOM), it is helping commissioners to monitor and evaluate the impact of rehabilitation services across the UK.

Innovation in New Technologies

To complete the first ever BSRM satellite symposium, Keith Foster, VP Scientific Affairs, Toxins, Syntaxin (an Ipsen Company) rounded off the innovation theme with a presentation that highlighted how, by developing a range of botulinum neurotoxins, it may be possible to relieve the suffering from highly debilitating conditions such as spasticity.

Keith explained that Syntaxin have an ambitious plan to produce new and enhanced Botulinum Neurotoxins (BoNTs) with multiple therapeutic applications and to develop new formulations and new toxins that will considerably expand the spectrum of clinical applications and better address patients’ needs (See Figure 1).

ACNRJF15-25b

Figure 1 – Innovation in new technologies.

References

  1. Rummel A, et al. FEBS J 2011; 278:4506-15.
  2. Wang J, et al. Biochem J 2012; 444:59-67.
  3. US Patent Application 20070299008; Kind Code A1; Rummel, Andreas; December 27, 2007. Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells. [www.formulascan.com/public/appl20070299008.html].
  4. Rummel A, et al. Toxicon 2013; 68:122-3. [Abstract].
  5. Guo J, et al. Toxicon 2013; 74:158-66.
  6. Wang D, et al. Biochem 2011;50: 2711-13.
  7. Chen S, Barbieri JT. Proc Natl Acad Sci 2009;106: 9180-84.

Ipsen organised and funded this symposium and has funded the preparation of this Highlights report. Ipsen has had no editorial input into this item other than to check accuracy of claims.

December 2014 UK/DYS08882v(1)


ACNR 2015;14(6);25.  Online 22/01/15

SIGN UP FOR OUR MAILING LIST

Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

This website is for medical professionals only.